Seeking Alpha rated Axon Enterprise a "Sell," citing concerns over high valuation and slowing U.S. growth momentum. The author argues future growth depends on accelerating international and enterprise segments to offset a domestic slowdown.
The report suggests minimal stock upside, even if Axon meets its 2028 financial targets. Axon's stock declined significantly over the past month. Investor concerns fueled the drop, including a recent $1 billion convertible note offering, potential share dilution, and the company's withdrawal of its free cash flow guidance.